Ultragenyx Pharmaceutical Inc. (RARE) Climbed 6.36% or 3.08 To Price $51.45 On Thursday


Ultragenyx Pharmaceutical Inc. (RARE) climbed 6.36% or 3.08 to $51.45. It is around 411256 shares traded, which is 62.83% compare to the average total volume 654554. The market cap of RARE is $2.60 billion. The year to date change is 4.51%. The 52 week price range is from $41.67 to $90.98. Price of RARE have changed -11.54% during last week. It have changed -21.70% over last month, -36.75% over last 3 months, -24.83% over last 6 months and 6.21% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RARE is 68.81. It is 33.74% above current price. The 200-day Moving Averages for RARE is 66.11. It is 28.49% above current price. The 52-week High is 90.98. It is 76.83% from the current price. The 52-week Low is 41.67. It is -19.01% from current price.

There are some statistics of RARE. It is has market cap $2.60 billion. The share outstanding is 50.58 million. The average volume is 654554. The revenue is 2.41M. The gross profit is 2.41M. The percent of top 15 Institution holding is 140.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RARE is -37.39%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RARE is -32.03%.


Tags:

Share this post